<![CDATA[NF1-PN Treatment Goals and Quality of Life
Impact]]>
Post Content: Source: Neurology Read More
<![CDATA[NF1 Diagnostic Criteria and Clinical
Recognition]]>
Post Content: Source: Neurology Read More
<![CDATA[CTAD Presentation Lays Insights Into
Disappointing Phase 3 EVOKE Trial of GLP-1 Semaglutide in Alzheimer
Disease]]>
Post Content: Source: Neurology Read More
<![CDATA[Additional Insights From the U.S. POINTER
Study at CTAD 2025: Heather M. Snyder, PhD]]>
Post Content: Source: Neurology Read More
<![CDATA[NeuroVoices: Robert Alexander, MD, on the
Evolution of Antiamyloid Therapeutics in Alzheimer
Disease]]>
Post Content: Source: Neurology Read More
<![CDATA[CTAD Poster Shows Etalanetug Reduced Tau
Pathology Biomarkers in Dominantly Inherited Alzheimer
Disease]]>
Post Content: Source: Neurology Read More
<![CDATA[Alzheimer Trial PRImus-AD Tests Orally
Available PRI-002 as New Treatment]]>
Post Content: Source: Neurology Read More








